Aprepitant

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Phase 2 Bunionectomy HTX-011 Administration Study

Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery

Topical Aprepitant in Prurigo Patients

Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer

Comparison of Adding EMEND to PONV/PDNV Treatment Regimen

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

Aprepitant for Post-operative Nausea

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy

Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery

Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy